6-K

AURINIA PHARMACEUTICALS INC. 6-K

Company: Aurinia Pharmaceuticals Inc.
Filed: July 11, 2018
Period of Report: July 11, 2018
Accession Number: 0001157523-18-001402

View Document ↗ View on SEC.gov ↗